Eric Fischer

Assistant Professor of BCMP, Dana Farber Cancer Institute
When
16th-17th Nov 2020
Start Time 08:50 (GMT, UTC)
Where
Virtual Conference
Attracting leading industry and academic experts in Medicinal Chemistry, this two-day event will bring together over 35 speakers to explore innovative new research in Protein Degradation and consider novel approaches to DNA Encoded Libraries, Phenotypic Screening and implementing Artificial Intelligence in the drug discovery process.
In addition, a special one-day symposium on Cannabinoid Drug Discovery will explore in detail the latest drug discovery developments from leading biotech and pharmaceutical companies targeting the endocannabinoid system (ECS), and creating a new class of regulated therapeutics.
“Good talks from major pharma companies about the different challenges they face and the solutions that they are applying”
“Great mix between solution provider, industrial delegates and academics”
“Networking opportunities and the excellent scientific level of the presentations”
“Very exciting program with prominent speakers”
Once again this hugely successful senior-level R&D event will be co-located with the 4th Global Pharma R&D AI, Data Science and Informatics Summit (PRADI 2020) which also explores machine learning and AI in Drug Discovery.
Watch this video from the 2019 meeting
×
Protein Degradation
Independent Group Leader, TU Dortmund
Senior Director DEL Strategy and Operations, Wuxi Apptec
Research Group Leader, TU Dortmund University, Germany
Founder and Chief Technology Officer, 1859 Inc.
Research Fellow, Arvinas
Research Scientist in Organic and Medicinal Chemistry, The University of Dundee
SVP Drug Discovery, Insitro
Principal Scientist, Pfizer
Senior Scientist, Medicinal Chemistry, Nurix Therapeutics
Hanna H. Gray Fellow, Crews Lab, University of Yale
Vice President Business Development, Eurofins Villapharma
Vice President, Head of Drug Discovery, Kymera Therapeutics
Associate Director of Chemistry and Alliances, Vipergen
Co-Founder and Lead ML Scientist, Dyno Therapeutics
Team Leader in Medicinal Chemistry, GSK
Applications Specialist, CAS
CEO, Plexium
Director of Medicinal Chemistry, AstraZeneca
Chief Decision Scientist, Exscientia
Head of Biology, Amphista Therapeutics Ltd.
Senior Research Scientist, Early CVRM Medicinal Chemistry, R&D Biopharmaceuticals, AstraZeneca
Head of Medicinal Chemistry, Early Respiratory, Inflammation and Autoimmunity, AstraZeneca
Head of Search & Evaluation Discovery Technologies, Merck Healthcare
Vice President, Head of Computational Molecular Design, Bayer
Vice President Medicinal Chemistry, Bayer
CSO, Numerate
Vice President, Medicinal Chemistry, Cullgen
Head Chemical Biology & Therapeutics Basel, Novartis
CEO, ChemPass Ltd.
Associate Professor, Molecular Therapeutics Group, Fox Chase Cancer Center USA
Director New Therapeutic Discovery, Boehringer Ingelheim
Portfolio Lead, Scientific Informatics, Dassault Systèmes BIOVIA.
Assistant Professor of BCMP, Dana Farber Cancer Institute
Senior Scientific Director, GSK
Director, BD and Solutions Engineering, Mcule
Independent Group Leader, TU Dortmund
Senior Director DEL Strategy and Operations, Wuxi Apptec
Research Group Leader, TU Dortmund University, Germany
Founder and Chief Technology Officer, 1859 Inc.
Research Fellow, Arvinas
Research Scientist in Organic and Medicinal Chemistry, The University of Dundee
SVP Drug Discovery, Insitro
Principal Scientist, Pfizer
Senior Scientist, Medicinal Chemistry, Nurix Therapeutics
Hanna H. Gray Fellow, Crews Lab, University of Yale
Vice President Business Development, Eurofins Villapharma
Vice President, Head of Drug Discovery, Kymera Therapeutics
Associate Director of Chemistry and Alliances, Vipergen
Co-Founder and Lead ML Scientist, Dyno Therapeutics
Team Leader in Medicinal Chemistry, GSK
Applications Specialist, CAS
CEO, Plexium
Director of Medicinal Chemistry, AstraZeneca
Chief Decision Scientist, Exscientia
Head of Biology, Amphista Therapeutics Ltd.
Senior Research Scientist, Early CVRM Medicinal Chemistry, R&D Biopharmaceuticals, AstraZeneca
Head of Medicinal Chemistry, Early Respiratory, Inflammation and Autoimmunity, AstraZeneca
Head of Search & Evaluation Discovery Technologies, Merck Healthcare
Vice President, Head of Computational Molecular Design, Bayer
Vice President Medicinal Chemistry, Bayer
CSO, Numerate
Vice President, Medicinal Chemistry, Cullgen
Head Chemical Biology & Therapeutics Basel, Novartis
CEO, ChemPass Ltd.
Associate Professor, Molecular Therapeutics Group, Fox Chase Cancer Center USA
Director New Therapeutic Discovery, Boehringer Ingelheim
Portfolio Lead, Scientific Informatics, Dassault Systèmes BIOVIA.
Assistant Professor of BCMP, Dana Farber Cancer Institute
Senior Scientific Director, GSK
Director, BD and Solutions Engineering, Mcule
At checkout in the additional notes field please tell us which track you will attend
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
£199.00
For foreign organisation delegate ticket fee
FREE
This pass gives you limited access to the meeting. Check the details above.
£799.00
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Dassault Systèmes, the 3DEXPERIENCE Company, provides business and people with virtual universes to imagine sustainable innovations. Its world-leading solutions transform the way products are designed, produced, and supported. Dassault Systèmes’ collaborative solutions foster social innovation, expanding possibilities for the virtual world to improve the real world. The group brings value to over 250, 000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com
×Mcule operates chemical marketplaces for drug discovery where you can order more than 170 million small-molecule samples from a high-quality database and request custom synthesis. You can utilize our aggregated supplier catalogs (Mcule database), 100M+ novel, synthetically accessible molecules (ULTIMATE database), rapid custom synthesis offers via our reverse auction site (SynthAgora), and the synergies between these three chemical marketplaces in your projects. Mcule’s services combine cheminformatic capabilities with our automated compound management laboratory to ensure that you quickly receive the right compounds in the requested assay-ready format.
×CAS is a specialist in scientific information solutions.
We curate, connect, and analyze scientific information revealing unique insights that accelerate breakthroughs. Leading commercial, government and academic institutions worldwide rely on CAS to turn scientific information into competitive advantages through:
Eurofins Discovery supports drug discovery through the combined expertise of Cerep, DiscoverX, Panlabs, Villapharma, and Selcia Drug Discovery. We offer a broad portfolio including medicinal and synthetic chemistry, in vitro pharmacology products and services, cell-based phenotypic assays, ADME-Tox, in vivo drug safety and efficacy, custom proteins, and assay development services.
https://www.eurofinsdiscoveryservices.com/
×Selvita is an integrated service company providing multidisciplinary support in resolving the unique challenges of research within area of drug discovery, regulatory studies, as well as research and development.
The company was established in 2007 and currently employs over 500 professionals. Selvita is headquartered in Krakow, Poland, with a second research site in Poznan, Poland and foreign offices located in Cambridge, MA and San Francisco Bay Area, in the U.S., as well as in Cambridge, UK.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. WuXi AppTec’s open-access platform is enabling more than 4,100 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that “every drug can be made and every disease can be treated”.
×Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions that accelerate and increase the efficiency of drug discovery and materials design. Founded in 1990, Schrödinger has nearly 400 employees and operations across the world. For more information, please visit www.schrodinger.com.
×ChemPass develops and utilizes software and technology for the pharmaceutical industry including a rule-based AI technology for multi-step in silico forward-synthesis that can be utilized for the design of novel synthetically feasible scaffolds and, lead analogs, or for various other general or targeted design tasks. The user friendly SynSpace software (and API) has been available for medicinal and computational chemists, while ChemPass provides lead optimization service using its automated design and ranking platform.
×Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings. Receive advanced delegate list from which to choose whom you’d like to meet with. Global Engage will schedule these meetings and send you an itinerary before the event
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness by taking a poster position or sponsoring the poster sessions. This can be supplemented by branding options such as placing your logo on the meeting background screen.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas. The booth allows you to provide a pre-recorded video or deliver a live video session to your visitors and capture emails when people register their interest. Live chat with your visitors in discussion groups or 1:1.
Options include:
For further details please contact
Tony Couch/Faizel Ismail
Telephone +44 (0) 1865 849841 or
email [email protected]
An STM journal publisher of online and print and open access journals, and related print/online book series, Bentham Science answers the informational needs of the pharmaceutical, biomedical and medical research community.
×BioVox is a specialized life sciences news and communication platform keeping you up to date on the rapidly evolving life sciences sector in Belgium and on global scientific and industry trends. BioVox brings exclusive news, in-depth interviews, opinions, and insights on healthcare, agriculture and the bio-based economy.
×Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry therefore keeping a tab on the updated and latest updates and trends concerning the field.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives.
×£199.00
For foreign organisation delegate ticket fee
FREE
This pass gives you limited access to the meeting. Check the details above.
£799.00
Fee for representatives of organisations offering services and/or business & technology solutions and also to business consultants.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.